{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:14:04Z","timestamp":1789150444708,"version":"build-2803163510"},"reference-count":54,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Telemedicine has played an important role in delivering healthcare for primary care, chronic disease patients, and those with solid organ malignancies. However, its application in subspecialties such as hematologic malignancies, hematopoietic cell transplantation (HCT), or chimeric antigen receptor-T cell (CAR-T) therapy is not widespread since physical examination is a vital component in delivering care. During the COVID-19 pandemic, we widely used telemedicine, since protecting our immunocompromised patients became our top priority. The employment of HCT and CAR-T therapies continues to grow for high-risk hematologic malignancies, particularly in older and frail patients who must visit specialty centers for treatment access. Generally, HCT and CAR-T therapy care is highly complex, necessitating commitment from patients, caregivers, and a multidisciplinary team at specialty academic centers. All healthcare systems adapted to the crisis and implemented rapid changes during the COVID-19 public health emergency (PHE). Telemedicine, a vital modality for delivering healthcare in underserved areas, experienced rapid expansion, regardless of the geographic region, during the COVID-19 PHE. The data emerging from practices implemented during the PHE are propelling the field of telemedicine forward, particularly for specialties with complex medical treatments such as HCT and CAR-T therapy. In this review, we examine the current data on telemedicine in HCT and cellular therapy care models for the acute and long-term care of our patients.<\/jats:p>","DOI":"10.3390\/cancers15164108","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T11:09:44Z","timestamp":1692097784000},"page":"4108","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy"],"prefix":"10.3390","volume":"15","author":[{"given":"Arpita P.","family":"Gandhi","sequence":"first","affiliation":[{"name":"Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Fred Hutch Cancer Research Center, Clinical Research Division, Seattle, WA 98109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira","year":"2020","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"796.e1","DOI":"10.1016\/j.jtct.2021.07.005","article-title":"Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients","volume":"27","author":"Mushtaq","year":"2021","journal-title":"Transplant. Cell Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjmed.2013.09.032","article-title":"Telemedicine, telehealth, and mobile health applicatiosn that work: Oppurtunities and barriers","volume":"127","author":"Weinstein","year":"2014","journal-title":"Am. J. Med."},{"key":"ref_4","unstructured":"Mechanic, O.J., Persaud, Y., and Kimball, A.B. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.2013.51.6765","article-title":"Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: The family CARE Randomized controlled trial","volume":"32","author":"Kinney","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/jgc4.1481","article-title":"Telehealth for genetic counseling: A systematic evidence review","volume":"30","author":"Danylchuk","year":"2021","journal-title":"J. Genet. Couns"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jgc4.1627","article-title":"An evidence-based practice guideline of the National Society of Genetic Counselors for telehealth genetic counseling","volume":"32","author":"Green","year":"2023","journal-title":"J. Genet. Couns"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bmt.2015.246","article-title":"Geographic access to hematopoietic cell transplantation services in the United States","volume":"51","author":"Delamater","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41409-022-01782-8","article-title":"Telehealth in hematopoietic cell transplantation: Perspective from patients at a public hospital in Brazil","volume":"57","author":"Cordeiro","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"207.e1","DOI":"10.1016\/j.jtct.2022.01.015","article-title":"Home-Based Hematopoietic Cell Transplantation in the United States","volume":"28","author":"Sung","year":"2022","journal-title":"Transplant. Cell Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2020006573","article-title":"House calls for stem cell transplant patients during the COVID-19 pandemic","volume":"136","author":"Sung","year":"2020","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"832.e1","DOI":"10.1016\/j.jtct.2022.09.014","article-title":"Pilot Trial of Homebound Hematopoietic Cell Transplantation","volume":"28","author":"Landau","year":"2022","journal-title":"Transplant. Cell Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e26121","DOI":"10.2196\/26121","article-title":"Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study","volume":"5","author":"Mussetti","year":"2021","journal-title":"JMIR Form Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181.e1","DOI":"10.1016\/j.jtct.2020.10.017","article-title":"Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients","volume":"27","author":"Racioppi","year":"2021","journal-title":"Transplant. Cell Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.bbmt.2020.02.004","article-title":"Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation","volume":"26","author":"Nawas","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41409-022-01664-z","article-title":"Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: Experience from a tertiary care center","volume":"57","author":"Borogovac","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjh.18339","article-title":"Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience","volume":"198","author":"Dholaria","year":"2022","journal-title":"Br. J. Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pedn.2018.07.007","article-title":"Customization of the TRU-PBMT App (Technology Recordings to better Understand Pediatric Blood and Marrow Transplant)","volume":"42","author":"Vaughn","year":"2018","journal-title":"J. Pediatr. Nurs."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/asheducation-2014.1.495","article-title":"Caring for the long-term survivor after allogeneic stem cell transplantation","volume":"2014","author":"Bhatia","year":"2014","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: The essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2017-03-775767","article-title":"An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease","volume":"130","author":"Martin","year":"2017","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.hemonc.2020.11.006","article-title":"Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era","volume":"14","author":"Hong","year":"2021","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/bloodadvances.2018026039","article-title":"High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation","volume":"3","author":"Miyamura","year":"2019","journal-title":"Blood Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.annonc.2021.09.001","article-title":"The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: An overview of systematic reviews","volume":"32","author":"Chan","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Savani, B.N., and Tichelli, A. (2021). Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant, Wiley. [2nd ed.].","DOI":"10.1002\/9781119612780"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2020.02.027","article-title":"Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease","volume":"26","author":"Chang","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"616.e1","DOI":"10.1016\/j.jtct.2021.03.024","article-title":"Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease","volume":"27","author":"Turner","year":"2021","journal-title":"Transplant. Cell Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2352-3026(20)30176-9","article-title":"Following-up allogeneic transplantation recipients during the COVID-19 pandemic","volume":"7","author":"Messina","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11764-018-0693-9","article-title":"An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation","volume":"12","author":"Syrjala","year":"2018","journal-title":"J. Cancer Surviv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bbmt.2018.05.004","article-title":"Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors","volume":"24","author":"Syrjala","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lee, K., Shamunee, J., Lindenfeld, L., Ross, E., Hageman, L., Sedrak, M.S., Wong, F.L., Nakamura, R., Forman, S.J., and Bhatia, S. (2023). Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: A pilot randomized trial. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-10884-5"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e22069","DOI":"10.2196\/22069","article-title":"Smartphone-Enabled, Telehealth-Based Family Conferences in Palliative Care During the COVID-19 Pandemic: Pilot Observational Study","volume":"8","author":"Wu","year":"2020","journal-title":"JMIR mHealth uHealth"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.2011.38.4594","article-title":"Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation","volume":"30","author":"Khera","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.2016.16786","article-title":"Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial","volume":"316","author":"LeBlanc","year":"2016","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hoek, P.D., Schers, H.J., Bronkhorst, K., Vissers, C.P., and Hasselaar, J.G.J. (2017). The effect of weekly specialist palliative care teleconsultations in patients with advanced cancer -a randomized clinical trial. BMC Med., 15.","DOI":"10.1186\/s12916-017-0866-9"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-022-01044-1","article-title":"Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: \u201cCare Anywhere, Anytime\u201d","volume":"24","author":"Hui","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_37","unstructured":"Bosworth, A., Ruhter, J., Samson, L.W., Sheingold, S., Taplin, C., Tarazi, W., and Zuckerman, R. (2021). Medicare Beneficiary Use of Telehealth Visits: Early Data From the Start of COVID-19 Pandemic, Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services."},{"key":"ref_38","unstructured":"Samson, L., Tarazi, W., Turrini, G., and Sheingold, S. (2020). Medicare Beneficiaries\u2019 Use of Telehealth Services in 2020\u2014Trends by Beneficiary Characteristics and Location (Issue Brief no. HP-2021-27), Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services."},{"key":"ref_39","unstructured":"(2023, June 15). Tech Adoption Climbs Among Older Adults 2017. Available online: https:\/\/www.pewresearch.org\/internet\/2017\/05\/17\/tech-adoption-climbs-among-older-adults\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5539\/gjhs.v7n2p210","article-title":"An overview of chronic disease models: A systematic literature review","volume":"7","author":"Grover","year":"2014","journal-title":"Glob. J. Health Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cancers14081884","article-title":"Telemedicine and Its Past, Present, and Future Roles in Providing Palliative Care to Advanced Cancer Patients","volume":"14","author":"Tang","year":"2022","journal-title":"Cancers"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13561-016-0141-3","article-title":"Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation\u2014A budget impact analysis from the healthcare perspective","volume":"7","author":"Kaier","year":"2017","journal-title":"Health Econ. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"De Geest, S., Valenta, S., Ribaut, J., Gerull, S., Mielke, J., Simon, M., Bartakova, J., Kaier, K., Ecksterin, J., and Leppla, L. (2022). The SMILe integrated care model in allogeneic SteM cell TransplantatIon faciLitated by eHealth: A protocol for a hybrid effectiveness-implementation randomised controlled trial. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-022-08293-8"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101723","DOI":"10.1016\/j.ejon.2020.101723","article-title":"Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: A mixed-methods contextual analysis as part of the SMILe study","volume":"45","author":"Leppla","year":"2020","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1007\/s00520-021-06328-0","article-title":"Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study","volume":"29","author":"Leppla","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/PPA.S337117","article-title":"Exploring Stem Cell Transplanted Patients\u2019 Perspectives on Medication Self-Management and Electronic Monitoring Devices Measuring Medication Adherence: A Qualitative Sub-Study of the Swiss SMILe Implementation Science Project","volume":"16","author":"Ribaut","year":"2022","journal-title":"Patient Prefer. Adherence"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jnu.12621","article-title":"Implementation Science Meets Software Development to Create eHealth Components for an Integrated Care Model for Allogeneic Stem Cell Transplantation Facilitated by eHealth: The SMILe Study as an Example","volume":"53","author":"Leppla","year":"2021","journal-title":"J. Nurs. Scholarsh"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2019-127566","article-title":"Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed\/Refractory (R\/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT","volume":"134","author":"Bachier","year":"2019","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2019-127508","article-title":"Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed\/Refractory (R\/R) Large B Cell Lymphomas","volume":"134","author":"Abramson","year":"2019","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e002056","DOI":"10.1136\/jitc-2020-002056","article-title":"Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia","volume":"9","author":"Myers","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bbmt.2020.04.008","article-title":"Chimeric Antigen Receptor T cell therapy during the COVID-19 pandemic","volume":"26","author":"Bachanova","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_52","first-page":"757","article-title":"The Role of Advanced Practice Providers and Telemedicine in Reinventing Care: The Transition of a CAR T-Cell Transplantation Program to the Outpatient Setting","volume":"11","author":"LeBar","year":"2020","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/OP.20.01071","article-title":"Maximizing Home Time for Persons With Cancer","volume":"17","author":"Banerjee","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/CCI.21.00023","article-title":"Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health","volume":"5","author":"Banerjee","year":"2021","journal-title":"JCO Clin. Cancer Inform."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/16\/4108\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:34:04Z","timestamp":1760128444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/16\/4108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":54,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["cancers15164108"],"URL":"https:\/\/doi.org\/10.3390\/cancers15164108","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}